Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Equine Vet Sci ; 139: 105079, 2024 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-38718968

RESUMO

Persistent breeding induced endometritis (PBIE) is a significant cause of infertility in mares. The development of a safe, universal, readily available therapeutic to manage PBIE and facilitate an optimal uterine environment for embryo development may improve pregnancy rates in susceptible mares. Mesenchymal stromal cells (MSCs) are being used increasingly as a therapeutic mediator for inflammatory conditions such as endometritis, and early gestational tissue provides a unique source of multipotent stem cells for creating MSCs. Extracellular vesicles (EVs) are mediators of cell communication produced by many different cell types. This study utilized embryo-derived mesenchymal stromal cells (EDMSCs) and their EVs as a potential therapeutic modality for PBIE in two groups: a) PBIE-susceptible mares challenged with pooled dead sperm (n=5); and b) client-owned mares diagnosed as susceptible to PBIE (n=37 mares and 40 estrous cycles). Mares pre-treated with intrauterine EDMSCs or their EVs resulted in a significant reduction in the accumulation of intrauterine fluid post-breeding. Nine of 19 (47 %) mares treated with EDMSCs prior to natural breeding and 13 of 20 (65 %) mares treated with EDMSC derived EVs were pregnant after the first cycle and 12 of 18 (67 %) mares treated with EDMSCs, and 15 of 19 (79 %) mares treated with EVs conceived by the end of the breeding season. These preliminary clinical studies are the first reports of the use of EDMSCs or their EVs as a potential intrauterine therapy for the management of PBIE susceptible mares.

2.
Sovrem Tekhnologii Med ; 13(3): 41-44, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34603754

RESUMO

The aim of the investigation was to study a systemic level of L-DOPA, dopamine, and norepinephrine, and assess their prognostic value in retinopathy of prematurity (ROP) development on an experimental disease model. MATERIALS AND METHODS: The investigation was carried out on infant Wistar rats (n=36) divided into a study group (rat infants with experimental ROP, n=17) and a control group (n=19). The animals of both groups were sacrificed on days 14, 21-23, and on days 28-30. The choice of the indicated periods corresponded to the key stages of ROP development in an experiment and was based on the findings of our previous histological studies. Dopamine, L-DOPA, and norepinephrine levels in infant rat blood plasma samples were determined. RESULTS: On day 14 of the experiment (the period corresponds to the pathological neovascularization induction in the applied model and preclinical ROP in children), mean L-DOPA level in infant rats with ROP (0.31 ng/ml) was significantly decreased compared to that in the controls (0.42 ng/ml) (p≤0.01). On days 21-23 of the experiment (the period corresponds to the growth of pathological extraretinal neovascularization in the applied model and ROP stage 3 in children) the systemic level of L-DOPA was still statistically reduced in the study group (0.87 ng/ml) compared to the control group (1.53 ng/ml) (p≤0.01). On days 28-30 of the experiment (the period corresponds to the regress of neovasculature in the applied model and a spontaneous ROP regress stage in children) the L-DOPA level in blood plasma in the study group (0.33 ng/ml) showed an insignificant upward tendency in reference to the controls (0.21 ng/ml). Mean dopamine and norepinephrine levels had no difference in the groups under study of infant rats within all follow-up periods. CONCLUSION: Low systemic level of L-DOPA at the preclinical stage of experimental ROP should be considered as a laboratory prognostic criterion of a developing pathological process; it will enable to use the criterion when working out the measures to optimize the existing screening system for the disease in children.


Assuntos
Retinopatia da Prematuridade , Animais , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Prognóstico , Ratos , Ratos Wistar , Retinopatia da Prematuridade/diagnóstico
3.
Biochemistry (Mosc) ; 66(8): 865-74, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11566056

RESUMO

Although it was shown earlier that phosphorylation of Na,K-ATPase by cAMP-dependent protein kinase (PKA) occurs in intact cells, the purified enzyme in vitro is phosphorylated by PKA only after treatment by detergent. This is accompanied by an unfortunate side effect of the detergent that results in complete loss of Na,K-ATPase activity. To reveal the effect of Na,K-ATPase phosphorylation by PKA on the enzyme activity in vitro, the effects of different detergents and ligands on the stoichiometry of the phosphorylation and activity of Na,K-ATPase from duck salt glands (alpha1beta1-isoenzyme) were comparatively studied. Chaps was shown to cause the least inhibition of the enzyme. In the presence of 0.4% Chaps at 1 : 10 protein/detergent ratio in medium containing 100 mM KCl and 0.3 mM ATP, PKA phosphorylates serine residue(s) of the Na,K-ATPase with stoichiometry 0.6 mol Pi/mol of alpha-subunit. Phosphorylation of Na,K-ATPase by PKA in the presence of the detergent inhibits the Na,K-ATPase. A correlation was found between the inclusion of P(i) into the alpha-subunit and the loss of activity of the Na,K-ATPase.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Detergentes/metabolismo , Glândula de Sal/enzimologia , ATPase Trocadora de Sódio-Potássio/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Detergentes/farmacologia , Patos , Ativação Enzimática/fisiologia , Fosfoaminoácidos/química , Fosfoaminoácidos/metabolismo , Fosforilação/efeitos dos fármacos , Subunidades Proteicas , ATPase Trocadora de Sódio-Potássio/química , ATPase Trocadora de Sódio-Potássio/efeitos dos fármacos
4.
Anal Biochem ; 277(2): 221-7, 2000 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-10625509

RESUMO

Prior strategies to measure inositol 1,4,5-trisphosphate (IP(3)) in single cells either have been qualitative or have had a limited spatial resolution. Capillary electrophoresis combined with a biological detector cell has been used to quantitate IP(3) in small regions of a Xenopus oocyte. To improve the detection limits of this method, we elucidated the experimental parameters which influenced the sensitivity and reliability of the IP(3)-detector cell coupled to capillary electrophoresis. The variables which influenced the detector cell were the magnitude of the voltage drop across the detector cell, the duration of this voltage drop, the direction of fluid flow in the capillary, the concentration of free Ca(2+) around the detector cell, and the presence of protease inhibitors during permeabilization of the detector cell. For the sample volumes imposed by the capillary diameter, the detector cell acted primarily as an IP(3) mass detector rather than a concentration detector. Characterization of the experimental variables influencing the sensitivity and reliability of this detector cell has the potential to enhance other analyte measurements performed by mating capillary electrophoresis with a biological detector cell.


Assuntos
Técnicas Biossensoriais , Eletroforese Capilar/métodos , Inositol 1,4,5-Trifosfato/análise , Animais , Linhagem Celular
5.
Biosci Rep ; 19(2): 109-14, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10888473

RESUMO

A 100-kDa protein that is a main component of the microsomal fraction from rabbit gastric mucosa is phosphorylated by cAMP-dependent protein kinase (PKA) in the presence of 0.2% Triton X-100. Microsomes from rabbit gastric mucosa possess activity of H,K-ATPase but not activity of Na,K-ATPase. Incubation of microsomes with 5 microM fluorescein 5'-isothiocyanate (FITC) results in both an inhibition of H,K-ATPase and labeling of a protein with an electrophoretic mobility corresponding to the mobility of the protein phosphorylated by PKA. The data suggest that the alpha-subunit of H,K-ATPase can be a potential target for PKA phosphorylation.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Mucosa Gástrica/metabolismo , ATPase Trocadora de Hidrogênio-Potássio/metabolismo , Microssomos/metabolismo , Animais , Inibidores Enzimáticos/farmacologia , Fluoresceína-5-Isotiocianato/metabolismo , Corantes Fluorescentes/metabolismo , ATPase Trocadora de Hidrogênio-Potássio/química , Radioisótopos de Fósforo , Fosforilação , Cloreto de Potássio/farmacologia , Inibidores da Bomba de Prótons , Coelhos , Cloreto de Sódio/farmacologia
6.
Biochemistry (Mosc) ; 62(1): 54-61, 1997 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9113730

RESUMO

The inhibition of Na,K-ATPase from duck salt gland and Ca-ATPase from rabbit skeletal muscle sarcoplasmic reticulum by melittin, a 26-residue peptide from bee venom, was studied. Melittin irreversibly inhibits both enzymes. At melittin/ATPase molar ratio (30-50):1, the time dependence of the inhibition is described by the sum of two exponential curves. At pH 7.0, the fast phase of the inhibition provides for about 50% of total loss of activity with pseudo-first order rate constants of 1.52 +/- 0.17 and 1.20 +/- 0.21 min-1 for Na,K- and Ca-ATPase, respectively. The corresponding pseudo-first order rate constants for the slow phase were 0.12 +/- 0.02 and 0.09 +/- 0.02 min-1. The inhibition of both enzymes by melittin depends upon pH; the inhibition increases when the pH is increased from 6.0 to 8.5. The enhancement of the inhibition concomitant to increase in pH is mainly due to an increase in the rate constant of the fast phase. ATP protects both enzymes from the inhibition by melittin; however, the character of protection is different for Ca-versus Na,K-ATPase. The protection of Ca-ATPase activity by ATP is due to an increase in melittin-insensitive activity. The protective effect of ATP on Na,K-ATPase is due to a decrease in the rate constant of fast phase as well as an increase in melittin-insensitive activity. The data suggest that the inhibition of Ca- and Na,K-ATPases by melittin results from the interaction of the peptide with two different sites. One of the sites may be located on the catalytic subunit of the enzymes, the other can be related to the lipid bilayer of the membrane.


Assuntos
ATPases Transportadoras de Cálcio/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Meliteno/farmacologia , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , Animais , Concentração de Íons de Hidrogênio , Bicamadas Lipídicas , Músculo Esquelético/enzimologia , Coelhos , Glândula de Sal/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...